CN100526300C - 生产4-硝基咪唑化合物的方法 - Google Patents

生产4-硝基咪唑化合物的方法 Download PDF

Info

Publication number
CN100526300C
CN100526300C CNB2005800053101A CN200580005310A CN100526300C CN 100526300 C CN100526300 C CN 100526300C CN B2005800053101 A CNB2005800053101 A CN B2005800053101A CN 200580005310 A CN200580005310 A CN 200580005310A CN 100526300 C CN100526300 C CN 100526300C
Authority
CN
China
Prior art keywords
replace
alkyl
halogen
unsubstituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005800053101A
Other languages
English (en)
Chinese (zh)
Other versions
CN1922154A (zh
Inventor
新滨光一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of CN1922154A publication Critical patent/CN1922154A/zh
Application granted granted Critical
Publication of CN100526300C publication Critical patent/CN100526300C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dentistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
CNB2005800053101A 2004-02-18 2005-02-15 生产4-硝基咪唑化合物的方法 Expired - Fee Related CN100526300C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2004041381 2004-02-18
JP041381/2004 2004-02-18
JP278999/2004 2004-09-27
JP2004278999 2004-09-27

Publications (2)

Publication Number Publication Date
CN1922154A CN1922154A (zh) 2007-02-28
CN100526300C true CN100526300C (zh) 2009-08-12

Family

ID=34863488

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005800053101A Expired - Fee Related CN100526300C (zh) 2004-02-18 2005-02-15 生产4-硝基咪唑化合物的方法

Country Status (19)

Country Link
US (1) US7569702B2 (enExample)
EP (1) EP1720838B1 (enExample)
JP (1) JP4789483B2 (enExample)
KR (1) KR100830386B1 (enExample)
CN (1) CN100526300C (enExample)
AR (1) AR047672A1 (enExample)
AT (1) ATE366241T1 (enExample)
AU (1) AU2005212093B2 (enExample)
BR (1) BRPI0507777A (enExample)
CA (1) CA2555372A1 (enExample)
DE (1) DE602005001553T2 (enExample)
EG (1) EG24393A (enExample)
ES (1) ES2289695T3 (enExample)
MY (1) MY141776A (enExample)
RU (1) RU2345071C2 (enExample)
TW (1) TWI300409B (enExample)
UA (1) UA82773C2 (enExample)
WO (1) WO2005077913A1 (enExample)
ZA (1) ZA200606332B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI331607B (en) * 2002-10-15 2010-10-11 Otsuka Pharma Co Ltd 1-substituted-4-nitroimidazole compound
TW200624422A (en) * 2004-09-27 2006-07-16 Otsuka Pharma Co Ltd Process for production of 2-chloro-4-nitroimidazole
JP5072675B2 (ja) * 2007-04-03 2012-11-14 四国化成工業株式会社 ２−ハロイミダゾール化合物の製造方法
WO2010021409A1 (en) 2008-08-21 2010-02-25 Dynamit Nobel Gmbh Explosivstoff - Und Systemtechnik Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof
RU2542988C2 (ru) * 2009-07-31 2015-02-27 Глоубал Элаенс Фор Тб Драг Дивелопмент Нитроимидазооксазины и их применения при противотуберкулезной терапии
CN103265494A (zh) * 2013-05-28 2013-08-28 南京理工大学 一种硝基咪唑含能化合物及其制备方法
CN105439957B (zh) * 2015-11-24 2018-05-08 浙江省诸暨合力化学对外贸易有限公司 一种合成2-溴-4-硝基咪唑的方法
KR20200116118A (ko) 2018-01-29 2020-10-08 오츠카 세이야쿠 가부시키가이샤 2-클로로-4-니트로이미다졸 유도체의 제조 방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341548A (en) * 1964-04-29 1967-09-12 Hoffmann La Roche Nitroimidazoles and their preparation
US4021442A (en) * 1974-03-25 1977-05-03 Basf Aktiengesellschaft Production of 1-alkyl-5-nitroimidazoles
US4925949A (en) * 1988-01-15 1990-05-15 Rhone-Poulenc Sante Process for preparing 1-alkyl-5-nitroimidazoles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2049780C1 (ru) * 1992-12-04 1995-12-10 Государственный научно-исследовательский институт "Кристалл" Способ получения производных 2-r-4(5)-нитроимидазолов
US5668127A (en) 1995-06-26 1997-09-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof
TWI347946B (en) 2002-10-11 2011-09-01 Otsuka Pharma Co Ltd 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
TWI331607B (en) * 2002-10-15 2010-10-11 Otsuka Pharma Co Ltd 1-substituted-4-nitroimidazole compound

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341548A (en) * 1964-04-29 1967-09-12 Hoffmann La Roche Nitroimidazoles and their preparation
US4021442A (en) * 1974-03-25 1977-05-03 Basf Aktiengesellschaft Production of 1-alkyl-5-nitroimidazoles
US4925949A (en) * 1988-01-15 1990-05-15 Rhone-Poulenc Sante Process for preparing 1-alkyl-5-nitroimidazoles

Also Published As

Publication number Publication date
RU2345071C2 (ru) 2009-01-27
EG24393A (en) 2009-04-19
DE602005001553T2 (de) 2008-03-13
ATE366241T1 (de) 2007-07-15
AU2005212093A1 (en) 2005-08-25
BRPI0507777A (pt) 2007-07-17
MY141776A (en) 2010-06-30
AR047672A1 (es) 2006-02-01
WO2005077913A1 (en) 2005-08-25
AU2005212093B2 (en) 2008-04-03
RU2006133312A (ru) 2008-03-27
ES2289695T3 (es) 2008-02-01
EP1720838A1 (en) 2006-11-15
HK1097846A1 (zh) 2007-07-06
CA2555372A1 (en) 2005-08-25
CN1922154A (zh) 2007-02-28
JP2006117628A (ja) 2006-05-11
TWI300409B (en) 2008-09-01
DE602005001553D1 (de) 2007-08-16
EP1720838B1 (en) 2007-07-04
JP4789483B2 (ja) 2011-10-12
KR20060116857A (ko) 2006-11-15
US7569702B2 (en) 2009-08-04
US20070161802A1 (en) 2007-07-12
TW200530194A (en) 2005-09-16
UA82773C2 (uk) 2008-05-12
KR100830386B1 (ko) 2008-05-19
ZA200606332B (en) 2008-01-30

Similar Documents

Publication Publication Date Title
Masters et al. On the importance of an acid additive in the synthesis of pyrido [1, 2‐a] benzimidazoles by direct copper‐catalyzed amination
CN100526300C (zh) 生产4-硝基咪唑化合物的方法
JP5014315B2 (ja) ４−ニトロイミダゾール化合物の製造法
Riccardi et al. Stability Is Not Everything: The Case of the Cyclisation of a Thrombin‐Binding Aptamer
Brnardic et al. Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors
Nikitidis et al. Synthetic and chromatographic challenges and strategies for multigram manufacture of KRASG12C inhibitors
US9879044B2 (en) Methods, compositions, and kits using heterogeneous catalysts
Ameen et al. Click chemistry based synthesis of novel architectures bearing sugar unit at the pyridothienopyrimidines
Aravinda et al. 1, 2, 3-triazole fused quinoline-peptidomimetics: studies on synthesis, DNA binding and photonuclease activity
Tosoni et al. The versatile NDI-based compounds: emerging anticancer and antimicrobial agents
WO2017103587A1 (en) Substituted naphthalene diimides and their use
CN113372344B (zh) 一种氯代六元含氮杂环并咪唑类化合物的合成方法
HK1097846B (en) Method for producing 4-nitroimidazole compound
CN109180578B (zh) 一种博舒替尼的制备方法
JP4163821B2 (ja) オリゴヌクレオチドの修飾方法
Kan et al. The synthesis and evaluation of a series of novel fused rings based benzothiazole derivatives as potent Polθ inhibitors
Zeghida et al. Application of 2, 2, 2-trichloroethoxycarbonyl protection to aminoacridines
Ekhato et al. The synthesis of radiolabeled Irbesartan using N, N‐dimethyl [14C] formamide as a source of carbon‐14 isotope
IT8222986A1 (it) Procedimento per la produzione di 2-ammino-4-idrossi-5-alogeno-pirimidine
CN107805221A (zh) 一种制备1h‑吲唑衍生物的方法
CN117561267A (zh) 硼酸化合物及其制造方法
CN104650094A (zh) 异吲哚并三唑化合物的制备方法
CN119330880A (zh) 一种由二氢喹啉酮系列化合物脱氢制备喹啉酮系列化合物的方法
MXPA06009262A (en) Method for producing 4-nitroimidazole compound
Molnár Selected reactions of 4h-pyrido [1, 2-a] pyrimidin-4-ones and an azoxyquinoxaline

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1097846

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1097846

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090812

Termination date: 20170215

CF01 Termination of patent right due to non-payment of annual fee